Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Goldman recommends buying Allergan (AGN +0.2%) on its recent pullback, saying the company is...

  • Friday, May 25, 2012, 10:10 AM ET
    Goldman recommends buying Allergan (AGN +0.2%) on its recent pullback, saying the company is well positioned with its diversified portfolio, emerging market exposure, and high growth potential. The firm reiterates its Buy rating with a $106 price target.
Track new comments on this story

This news story has 1 comment:

  •  
    If Goldman Sachs is telling you to buy it, it's because they are shorting it!
    25 May 2012, 10:39 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »